Long non-coding RNA LINC00426 contributes to doxorubicin resistance by sponging miR-4319 in osteosarcoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long non-coding RNA LINC00426 contributes to doxorubicin resistance by sponging miR-4319 in osteosarcoma
Authors
Keywords
-
Journal
Biology Direct
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-03
DOI
10.1186/s13062-020-00265-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-4319 suppresses colorectal cancer progression by targeting ABTB1
- (2019) Longchang Huang et al. United European Gastroenterology Journal
- Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy
- (2019) Qiang Cai et al. Molecular Cancer
- MiR-4319 hinders YAP expression to restrain non-small cell lung cancer growth through regulation of LIN28-mediated RFX5 stability
- (2019) Yi Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- LncRNA LOXL1‐AS1/miR‐let‐7a‐5p/ EGFR ‐related pathway regulates the doxorubicin resistance of prostate cancer DU‐145 cells
- (2019) Tianliang Bai et al. IUBMB LIFE
- miR‐4319 inhibited the development of thyroid cancer by modulating FUS‐stabilized SMURF1
- (2019) Shuquan Bian JOURNAL OF CELLULAR BIOCHEMISTRY
- Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer
- (2019) Xu Liu et al. CANCER LETTERS
- MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer
- (2018) Manxin Xie et al. BIOMEDICINE & PHARMACOTHERAPY
- Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis
- (2018) Binghua Zhou et al. BIOMEDICINE & PHARMACOTHERAPY
- The challenge of drug resistance in cancer treatment: a current overview
- (2018) Michail Nikolaou et al. CLINICAL & EXPERIMENTAL METASTASIS
- MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway
- (2018) Tao Tian et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Fibronectin-1 modulated by the long noncoding RNA OIP5-AS1/miR-200b-3p axis contributes to doxorubicin resistance of osteosarcoma cells
- (2018) Zhu Kun-Peng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The functions and unique features of long intergenic non-coding RNA
- (2017) Julia D. Ransohoff et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy
- (2017) Zhengguang Wang et al. Oncotarget
- MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1
- (2016) Bo-chuan Lin et al. MEDICAL SCIENCE MONITOR
- MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1
- (2015) Yuanmin Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal
- (2015) Suoyuan Li et al. TUMOR BIOLOGY
- Competing endogenous RNA networks and gastric cancer
- (2015) Lei-Lei Guo WORLD JOURNAL OF GASTROENTEROLOGY
- A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing theHMGB1andKATNAL1genes
- (2014) Deborah Bartholdi et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- The Multidisciplinary Management of Osteosarcoma
- (2009) Noah Federman et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation